Zu den Deals
Gesundheitswesen

InNeuroCo has been acquired by Integer

The owners of InNeuroCo has sold the company to Integer (NYSE:ITGR).

Founded in 2014 and headquartered in Pembroke Pines, Florida, InNeuroCo is a leading founder-owned designer and contract manufacturer of ultra-precise, highly engineered neurovascular catheters. InNeuroCo’s primary products are single-use catheters principally used in interventional neurovascular procedures for the treatment of ischemic strokes and aneurysms. Offering turnkey product design and development, supported by comprehensive domestic manufacturing capabilities, InNeuroCo serves as a mission-critical supply partner to the world’s preeminent medical device OEMs.

With approximately US$1.4 billion in annual revenue, Integer is one of the largest medical devices outsource manufacturers in the world, serving the cardiac, vascular, rhythm management and neuromodulation markets.

Oaklins TM Capital in the US served as the exclusive financial advisor to InNeuroCo in its sale to Integer (NYSE:ITGR).

Parteien
„InNeuroCo’s founders have enjoyed a long-standing history of success with the Oaklins TM healthcare team. When we began contemplating a transaction for InNeuroCo, it was the obvious choice to serve as our advisor. Throughout this transaction, their knowledge of the neurovascular sector, valuable strategic insights and demonstrated expertise in contract medical manufacturing were critical to engineering a successful outcome for InNeuroCo. We appreciate the team’s tireless dedication and thoughtful approach.“

Marc Litzenberg

President and CEO, InNeuroCo

Sprechen Sie mit dem Deal-Team

 James  McLaren

James McLaren

Geschäftsführer
New York, Vereinigte Staaten
Oaklins TM Capital
 Michael S. Goldman

Michael S. Goldman

Geschäftsführer
New York, Vereinigte Staaten
Oaklins TM Capital
 John  Dean

John Dean

Associate Director
Atlanta, Vereinigte Staaten
Oaklins TM Capital
 Bradley S. Goldstein

Bradley S. Goldstein

Associate Director
Atlanta, Vereinigte Staaten
Oaklins TM Capital
 Ariel  Fieldman

Ariel Fieldman

Associate
New York, Vereinigte Staaten
Oaklins TM Capital
 Matthew  Halbig

Matthew Halbig

Analyst
Atlanta, Vereinigte Staaten
Oaklins TM Capital

Relevante Transaktionen

Prestige Inhome Care has found a long-term strategic partner
Gesundheitswesen

Prestige Inhome Care has found a long-term strategic partner

Prestige Inhome Care has received a growth capital investment from Yorkway Private. The newly formed partnership will provide growth capital for geographic expansion, increasing Prestige’s range of services and potential future acquisitions. The investment in Prestige is in line with Yorkway’s mandate to invest in leading Australian mid-market companies with strong management teams, backed by significant growth tail winds, as is the case in the aged care industry.

Weitere Informationen
Cara Care has been acquired by Mahana Therapeutics
Private Equity | Gesundheitswesen | Technologie, Medien und Telekommunikation

Cara Care has been acquired by Mahana Therapeutics

Mahana Therapeutics Inc., renowned for its pioneering digital treatments targeting chronic health issues, has recently finalized the acquisition of Cara Care (HiDoc Technologies GmbH). Cara Care stands out as a premier digital health platform and an official digital health application (DiGA) dedicated to enhancing gut health. This acquisition, supported by key investors Lux Capital and Jazz Ventures Partners, perfectly aligns with Mahana’s expansion strategy.

Weitere Informationen
Apotheka acquires two pharmacy outlets from Panpharmacy
Konsumgüter & Handel | Gesundheitswesen

Apotheka acquires two pharmacy outlets from Panpharmacy

In a strategic move that signifies the ongoing consolidation and growth within the Latvian pharmaceutical retail sector, Panpharmacy, the parent company of the leading online pharmacy InternetAptieka.lv, has successfully completed the sale of two of its brick-and-mortar pharmacies to Apotheka. These pharmacies, both situated in the capital city of Riga, will continue to serve customers under the Apotheka brand, marking a seamless transition in ownership and operations.

Weitere Informationen